RBC Capital Maintains Outperform on Pharvaris, Raises Price Target to $52
RBC Capital analyst Brian Abrahams maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $51 to $52.
Read original at benzingaStocks · News reference
Wells Fargo Initiates Coverage On Pharvaris with Overweight Rating, Announces Price Target of $55
Wells Fargo analyst Yanan Zhu initiates coverage on Pharvaris (NASDAQ:PHVS) with a Overweight rating and announces Price Target of $55.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 15, 2026, 11:03 AM
- Checked
- Jul 15, 2026, 11:03 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $40
Guggenheim analyst Debjit Chattopadhyay maintains Pharvaris (NASDAQ:PHVS) with a Buy and raises the price target from $39 to $40.
Read original at benzingaCitizens Maintains Market Outperform on Pharvaris, Raises Price Target to $75
Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and raises the price target from $74 to $75.
Read original at benzingaPharvaris Q2 EPS $(0.81) Misses $(0.74) Estimate
Pharvaris (NASDAQ:PHVS) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.74) by 9.46 percent. This is a 13.83 percent increase over losses of $(0.94) per share from the
Read original at benzinga